E&G Advisors’s Elevance Health ELV Stock Holding History

E&G Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-530	Closed	-$206K	–	230
2025 Q2	$206K	Hold	530	–	–	0.05%	199
2025 Q1	$231K	Buy	+530	New	+$213K	0.07%	190
2024 Q4	–	Sell	-530	Closed	-$276K	–	220
2024 Q3	$276K	Hold	530	–	–	0.08%	177
2024 Q2	$287K	Buy	530 +100	+23%	+$52.9K	0.08%	167
2024 Q1	$223K	Hold	430	–	–	0.07%	188
2023 Q4	$203K	Sell	430 -70	-14%	-$32.4K	0.07%	187
2023 Q3	$218K	Sell	500 -50	-9%	-$22.7K	0.08%	181
2023 Q2	$244K	Hold	550	–	–	0.09%	178
2023 Q1	$253K	Hold	550	–	–	0.09%	172
2022 Q4	$282K	Sell	550 -100	-15%	-$50.8K	0.11%	163
2022 Q3	$295K	Buy	650 +100	+18%	+$47.8K	0.11%	153
2022 Q2	$265K	Buy	+550	New	+$272K	0.09%	175
2018 Q1	–	Sell	-900	Closed	-$203K	–	198
2017 Q4	$203K	Buy	+900	New	+$192K	0.09%	197

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

E&G Advisors's ELV Position: Q3 2025 in Review

E&G Advisors sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 530 shares — an estimated $206K sold.

E&G Advisors first reported a position in ELV in Q4 2017 and held it in 13 quarters. The position peaked at $295K in Q3 2022. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

E&G Advisors reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
E&G Advisors sold 530 Elevance Health shares in Q3 2025, an estimated $206K.
E&G Advisors first reported a position in Elevance Health in Q4 2017 and held it in 13 quarters.
E&G Advisors's Elevance Health position peaked at $295K in Q3 2022.
1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on E&G Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.